GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER
批准号:
7376428
负责人:
ARLENE B CHAPMAN
金额:
$8.8万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30
中文摘要
本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者(PI)可能已经从另一个NIH来源获得了主要资金,因此可以在其他CRISP条目中表示。列出的机构是中心的,不一定是研究者的机构。在考虑混杂因素(包括性别、年龄、体型和肾素-血管紧张素-醛固酮系统测量)的变化之前或之后,候选基因的变化(单独或联合考虑)对氢氯噻嗪或血管紧张素受体阻滞剂的血压反应的预测没有贡献。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Variation in candidate genes, considered as one or in combination, makes no contribution to the prediction of blood pressure response to hydrochlorothiazide or an angiotensin receptor blocker before or after considering variation in confounders including gender, age, body size, and measures of the renin angiotensin-aldosterone system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MRI Risk Classification in Children and Young Adults with ADPKD
-
批准号:10673378
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2022
-
负责人:ARLENE B CHAPMAN
-
依托单位:
Whole-Room Calorimeter
-
批准号:10431445
-
项目类别:
-
资助金额:$128.4万
-
财政年份:2022
-
负责人:ARLENE B CHAPMAN
-
依托单位:
Limited Competition for the Continuation of the Consortium for Radiologic Imaging
-
批准号:9274682
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2016
-
负责人:ARLENE B CHAPMAN
-
依托单位:
Limited Competition for the Continuation of the Consortium for Radiologic Imaging
-
批准号:9044528
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2015
-
负责人:ARLENE B CHAPMAN
-
依托单位:
Limited Competition: Clinical Centers for the HALT-Polycystic Kidney Disease Tria
-
批准号:7920518
-
项目类别:
-
资助金额:$11.01万
-
财政年份:2009
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GENETIC EPIDEMIOLOGY OF BLOOD PRESSURE RESPONSE TO ANGIOTENSIN RECEPTOR BLOCKER
-
批准号:7603688
-
项目类别:
-
资助金额:$2.54万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
HALT PROGRESSION OF POLYCYSTIC KIDNEY DISEASE
-
批准号:7603623
-
项目类别:
-
资助金额:$4.16万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
PHARMACOGENETIC EVALUATION OF ANTI-HYPERTENSIVE RESPONSE (PEAR)
-
批准号:7603690
-
项目类别:
-
资助金额:$3.2万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
THE ADPKD COHORT STUDY
-
批准号:7603645
-
项目类别:
-
资助金额:$0.13万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GERA-2 STUDY
-
批准号:7603656
-
项目类别:
-
资助金额:$0.64万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
HALT-PKD
-
批准号:7603689
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2006
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GERA-2 STUDY
-
批准号:7198980
-
项目类别:
-
资助金额:$15.97万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
ADPKD COHORT STUDY
-
批准号:7198995
-
项目类别:
-
资助金额:$1.74万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
ADPKD COHORT STUDY
-
批准号:7376427
-
项目类别:
-
资助金额:$1.21万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
PHARMACOGENETIC EVALUATION OF ANTI-HYPERTENSIVE RESPONSE (PEAR)
-
批准号:7376386
-
项目类别:
-
资助金额:$0.1万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GERA-2 STUDY
-
批准号:7376413
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
CRISP STUDY
-
批准号:7198974
-
项目类别:
-
资助金额:$8.81万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
GERA-2 STUDY
-
批准号:7198996
-
项目类别:
-
资助金额:$11.84万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
ENDOTHELIAL FUNCTION IN PATIENTS WITH AUTOSOMAL POLYCYSTIC KIDNEY DISEASE
-
批准号:7376406
-
项目类别:
-
资助金额:$0.02万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
THE ADPKD COHORT STUDY
-
批准号:7198969
-
项目类别:
-
资助金额:$19.08万
-
财政年份:2005
-
负责人:ARLENE B CHAPMAN
-
依托单位:
海外基金